Přihlásit se Zaregistrujte se zdarma

Rok IPO společnosti Agile Therapeutics Inc

Jaká je hodnota metriky Rok IPO společnosti Agile Therapeutics Inc?

Hodnota metriky Rok IPO společnosti Agile Therapeutics Inc je 2014

Jaká je definice metriky Rok IPO?

IPO je rok počáteční veřejné nabídky akcií společnosti, kdy se akcie společnosti začnou veřejně obchodovat.

Through IPO a privately held company transforms into a public company. Initial public offerings are mostly used by companies to raise the expansion of capital, possibly to monetize the investments of early private investors, and to become publicly traded enterprises. A company selling shares is never required to repay the capital to its public investors. After the IPO, when shares trade freely in the open market, money passes between public investors.

Although IPO offers many advantages, there are also significant disadvantages, chief among these are the costs associated with the process and the requirement to disclose certain information that could prove helpful to competitors.

The IPO process is colloquially known as going public. Details of the proposed offering are disclosed to potential purchasers in the form of a lengthy document known as a prospectus. Most companies undertake an IPO with the assistance of an investment banking firm acting in the capacity of an underwriter. Underwriters provide several services, including help with correctly assessing the value of shares.

Rok IPO společností v sektoru Health Care sektor na NASDAQ ve srovnání se společností Agile Therapeutics Inc

Čemu se věnuje společnost Agile Therapeutics Inc?

agile therapeutics is a forward-thinking women's healthcare company dedicated to fulfilling the unmet health needs of today's women. our product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill, without committing to a longer-acting method. our lead product candidate, twirla®, (ethinyl estradiol and levonorgestrel transdermal system), also known as ag200-15, is a once-weekly prescription contraceptive patch that recently completed phase 3 trials. twirla is based on our proprietary transdermal patch technology, called skinfusion®, which is designed to provide advantages over currently available patches and is intended to optimize patch adhesion and patient wearability. for more information, please visit the company website at www.agiletherapeutics.com. connect with us on twitter at @agilether.

Firmy s metrikou rok ipo podobnou společnosti Agile Therapeutics Inc